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Abstract
We studied the in vitro and in planta antiviral activity of the PhRIP I, a type 1 Ribosome-Inactivating Protein originally purified from leaves of
the Phytolacca heterotepala. This protein inhibited protein translation in a cell-free assay and limited the local lesion formation from PVX
infection on tobacco leaves. We used a transient expression system based on leaf infiltration with recombinant Agrobacteria to show that tobacco
can produce a correctly processed PhRIP I enzyme that retains its antiviral activity. Hence, it is possible to rapidly yield in plants a type 1 RIP by
means of this transient expression system. To analyse the possible increase of virus resistance in plants, Nicotiana tabacum lines that were
transformed with the PhRIP I coding sequence under the control of the wound-inducible PGIP promoter were challenged by PVX. A significantly
lower number of viral lesions compared to untransformed plants was observed only after the induction of the transgene, indicating that the
controlled gene expression of an antiviral protein can increase virus resistance.
# 2008 Elsevier Ireland Ltd. All rights reserved.
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1. Introduction
Ribosome-Inactivating Proteins (RIPs) are a family of RNA
N-glycosidases (EC 3.2.2.22) with a high site-specific dead-
enylation activity towards the large subunits of ribosomal RNA
[1–3]. Following the removal of a single adenine, protein
synthesis is inhibited as ribosomes are no longer able to bind
Elongation Factors. Therefore, when RIPs succeed in
penetrating the cytoplasm, protein synthesis is arrested and
the cell eventually dies [1]. Besides rRNA, RIPs deadenylate
other substrates such as DNA, and many of them also
depurinate natural or synthetic polynucleotides [4]. Conse-
quently, the name polynucleotide adenine glycosylase was
proposed for these proteins [5].
RIPs are classically subdivided in three groups according to
their molecular structure [2,3]. Many RIPs exist as monomers
of around 25–30 kDa (type 1 RIPs), highly active towards
ribosomes in vitro. Nonetheless, their cytotoxicity is limited by
their reduced ability to bind to and enter cells. Type 2 RIPs,
present in some plants, have an N-terminal RNA N-glycosidase
domain similar to type 1 RIPs (the A chain) that is joined to a C-
terminal carbohydrate-binding domain (the B chain) through a
single disulphide bond. These proteins can easily enter target
cells and among them there are some of the most potent
cytotoxins. Type 3 RIPs are proteins composed by an N-
terminal RNA N-glycosidase domain and an extended C-
terminal domain, whose function has not been completely
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clarified. Type 3 RIPs are synthesised in plants as larger
precursors and require proteolytic removal of an internal
peptide to be active.
Although different RIPs have been characterized, their
biological role in plants is not fully defined [6]. It is believed
that these proteins are mainly involved in plant defence [1] as
their constitutive expression in transgenic plants increases
resistance against different biotic stresses. However, ectopi-
cally expressed RIPs (e.g.: PAP, PAPII and trichosanthin)
caused an abnormal phenotype in the transgenics, with the
highest expression levels resulting in mottled plants with
yellow, smaller leaves [7,8]. Such constraint is not universal, as
the constitutive expression in plants of some other RIPs is not
associated to phenotypic abnormalities [9,10]. Additionally,
some mutant RIPs that lack ribonuclease activity proved to be
effective as antiviral proteins [11], although their stability and
usefulness in different plant species has been questioned by
some authors [9,12,13].
A defensive role for RIPs is also supported by the fact that
these proteins are present in large quantity in storage organs
such as seeds, roots or bulbs [1], because such accumulation
should provide an essential advantage against different
pathogens. Moreover, RIPs genes are differentially expressed
in relation to various conditions and treatments related to stress
[1]. For instance, in sugar beet the expression of beetins is
induced by viral infection and pathogenesis-related signalling
molecule [14]. Among Phytolacca plants, it has been reported
that the PIP2 (Phytolacca insularis antiviral protein) gene is
developmentally regulated and systemically induced in leaves
by wounding, jasmonic acid and ABA [15]. However, it has not
been determined if the inducible expression of RIPs in plants is
able to protect themselves from infecting viruses [15].
Type I RIPs are also of significant interest because of their
anti-HIV activity and more generally of their potential for
cancer therapy, especially after conjugation with antibodies or
other carrier moieties (immuno-toxins) [16]. Although the
potential pharmacological properties of RIPs are well-known,
further improvements are still needed [17] and to this aim it
would be valuable to have suitable heterologous systems to
express and purify variant proteins. Unfortunately, owing to
their intrinsic cytotoxicity, RIP expression may be problematic
in both bacteria and yeasts [18,19]. Despite some known
advantages [20], the possibility to use plants as a biosystem for
RIP production has been poorly explored [21], probably
because high RIP levels are correlated with phytotoxic effects.
The objectives of this work were to characterise the antiviral
properties of a type 1 RIP isolated from Phytolacca
heterotepala (Mexican pokeweed) in vitro and in planta and
to test the feasibility of a rapid transient expression system to
produce an active type 1 RIP in tobacco leaves.
2. Materials and methods
2.1. Determination of translation inhibitory activity
Experimental conditions for activity determinations were as
follows: reaction mixtures contained, in a final volume of
62.5 ml: 10 mM Tris/HCl buffer (pH 7.4), 100 mM ammonium
acetate, 2 mM magnesium acetate, 1 mM ATP, 0.2 mM GTP,
15 mM phosphocreatine, 0.63 mM creatine kinase, 0.05 mM
amino acids (minus leucine) (all from Sigma, St. Louis, MO,
USA), 89 nCi of L-[14C]-leucine (GE Healthcare, Milano,
Italy), scalar concentrations of protein and 25 ml of rabbit
reticulocyte lysate. Incubation was at 28 8C for 5 min. The
reaction was arrested with 1 ml of 0.1 M KOH, and two drops
of H2O2 were then added to eliminate possible interferences in
b-counter measuring. Proteins were precipitated by adding
1 ml of trichloroacetic acid (20% w/v). Precipitated proteins
were collected on glass-fibre discs and the incorporated
radioactivity was measured with a b-counter after the addition
of 5 ml of Ready Gel scintillation cocktail (Beckman, Milano,
Italy) containing 0.7% acetic acid. Data are media (S.D.) of
two experiments carried out in triplicate
2.2. Local lesion assay with the PhRIP I protein
Virus suspension inocula (100 ml) containing 0.5 mg/ml of
potato virus X (PVX) and various concentrations of PhRIP I in
50 mM Na–phosphate buffer (pH 7.2) were rubbed on to half
leaves ofNicotiana tabacum cv. SamsunNN using carborundum
(300 mesh) as an abrasive. A PVX inoculum in 50 mM Na–
phosphate buffer solution (pH 7.2) was used on each opposite
half leaf as a control and rubbed as before. Each treatment was
replicated 10 times and randomized on the leaves of the test
plants. Lesions were counted 7 days post-inoculation and the
percentage inhibition of local lesion formation was calculated
using the equation: percent of inhibition = 1 ÿ (number of
lesions on RIP + PVX half leaf/number of lesions on PVX
control half leaf)  100 [22]. The statistical significance of the
results was evaluated by a t-test.
2.3. Construction of plant expression vectors
For transient expression experiments the PhRIP I cDNAwas
cloned into a high copy number binary vector of the pGreen
series [23] using standard molecular techniques [24]. Unless
stated otherwise, all enzymes were purchased from Promega
(Milano, Italy) and were used according to the manufacturer’s
recommendations. Firstly, to mutagenise the Hind III site of the
pGreen0029 binary vector, this plasmid was cut with the Hind
III restriction enzyme, the ends filled-in by the Klenow
fragment of DNA I polymerase, and the resulting molecules
self-ligated by a T4 DNA ligase treatment, yielding the
pG0029M. Subsequently, the 50- and 30-regulatory sequences of
the 35S RNA CaMV gene were excised from p35S [23] using
EcoRVand ligated into a similarly digested pG0029M, yielding
the pG2935S. The PhRIP I cDNA coding sequence was
amplified using the Pfu DNA polymerase (Stratagene, Milano,
Italy) adding anHind III restriction site (bold face) to the 50 end
of both primers, 5HIIIRIP (50-CTC AAG CTTATG CTT GTG
GTG ACA ATA TTC) and 3RIPIII (50-CTC AAG CTT TTA
AGA ATT CTT CAA ATA GAT). After Hind III digestion, the
PCR fragments were gel purified and cloned into a similarly
digested pG2935S, yielding the pG2935SRIP vector. The
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correctness of the insert was verified by DNA sequencing. The
plasmids pG0029M and pG2935SRIP were mobilised along
with pSoup [23] into Agrobacterium tumefaciens (C5851
strain) cells by electroporation with a Bio-Rad MicroPulser,
according to the manufacturer’s instructions.
2.4. Plant culture and agroinfiltration
Infiltration with recombinant Agrobacteria (agroinfiltration)
was carried out using Nicotiana tabacum cv. Samsum NN
plants grown in controlled conditions (22 8C and a 16 h light/
8 h dark photoperiod). Young fully expanded leaves were
vacuum-infiltrated with recombinant Agrobacterium tumefa-
ciens cells as described [25]. After infiltration, leaves were
incubated in sealed trays on wet paper at 24 8C with a 16 h
light/8 h dark photoperiod. Then, the infiltrated leaves were
grounded in liquid nitrogen and resuspended into two volumes
of ice-cold extraction buffer (200 mM Tris, 5 mM EDTA,
4 mM DTT, pH 8.0). The suspension was cleared twice by
centrifugation (20,000  g for 30 min at 4 8C) before
immunoassay. For quantification, proteins were resolved on
12% SDS–PAGE and Western blot analysis was carried out
using the anti-PD-L4 sera diluted 1:1000 [26]. After washing,
bound antibodies were identified using the ECL chemilumi-
nescence-based detection kit (GE Healthcare) according to
manufacturer’s instructions and signal intensity was quantified
using the SigmaScan software v 5.0 (Jandel Scientific, Erkrath,
Germany). Quantification of the PhRIP I produced in tobacco
leaves was carried out in triplicate, by comparisons to scalar
amounts of the purified PhRIP I. As regression analysis
indicated a strong linear correlation between the amounts
employed and signal intensity (R2 > 0.97), the quantity of
PhRIP I in the protein extract was estimated solving the
regression equation.
2.5. Characterisation of the PhRIP I from tobacco
The following buffers have been used for the preparation of
the recombinant PhRIP I from leaves of Nicotiana tabacum:
buffer A: 5 mM Na–phosphate, pH 7.2; buffer B: 5 mM Na–
phosphate, pH 7.2 containing 0.14 M NaCl; buffer C: 10 mM
Na–acetate, pH 4.5; buffer D: 5 mM Na–phosphate, pH 7.2,
containing 1 M NaCl; buffer E: 5 mM Na–phosphate, pH 7.2,
containing 0.3 M NaCl.
The purification procedure from tobacco leaves was
accomplished using a general procedure for basic proteins
[27] with some modifications. Briefly, leaves (40 g) were
homogenized in 200 ml of buffer B by 20 s bursts at full power
using a Waring Blender (Waring Products, Torrington, USA).
Subsequently, the protein extract was subject to: (i) acid
precipitation (pH 4.0) with acetic acid, in order to use directly
soluble acid proteins in the following purification step; (ii) two
analytical chromatographies on the system Akta purifier
(Amersham Pharmacia, Milan, Italy): (i) loading of the protein
sample on the SourceTM 15S 4.6/100 PE column (Amersham
Pharmacia) equilibrated in buffer C; the column was then
washed with buffer A and eluted step-wise with buffer D; (ii)
HiLoad 16/60 SephadexTM 75 prep grade column (GE
Healthcare, Milano, Italy), equilibrated and eluted with buffer
E. Single eluted fractions from HiLoad 16/60 Sephadex were
assayed for polynucleotide–adenosine glycosidase activity
[27]. Active fractions with an elution volume corresponding
to about 30 kDa were pooled and further subjected Western
blotting [27]. Native proteins were separated by SDS–PAGE
and submitted to automated sequencing by Edman degradation.
After electrophoresis, proteins were transferred to PVDF
membrane (Applera, Monza, Italy) by electroblotting with the
mini trans-blot cell (Bio-Rad, Milano, Italy), according to the
manufacturer’s instructions in buffer F (10 mMCAPS, pH 11.0,
containing 10% methanol). PVDF membranes were then
stained for 1 min with Coomassie Blue R-250, destained with
the washing solution (50% methanol), dried and directly
analysed by Edman degradation on a Procise Model 491C
sequencer (Applied Biosystems, Foster City, USA) as reported
[28].
2.6. Analysis of the PhRIP I antiviral activity in transgenic
tobacco
The tobacco genetic transformation using the binary vector
pGIPRIP and the molecular characterization of the transfor-
mants (named PGIPRIP) were as described [26]. Briefly, in the
pGIPRIP plasmid, the cDNA encoding the PhRIP I was cloned
under the control of the wound-inducible PGIP promoter from
bean [29]. Plants of four independent transgenic lines (named
PGIPRIP 1, 2, 18 and 37) were used for the analysis of the
PhRIP I antiviral activity. Seeds were surface sterilized firstly
with 70% ethanol and then with 3% NaOCl containing 0.1%
Tween 20 as surfactant. The seeds were rinsed five times with
sterile water and germinated on MS medium supplemented
with 30 g of sucrose and 50 mg of kanamycin per liter. After 14
days seedlings were transferred to soil and grown in a growth
chamber (22 8C, 16 h light/8 h dark photoperiod) for 4 weeks.
For the induction of the wound-inducible promoter, two leaves
of 10 tobacco plants per line were wounded with a haemostat
perpendicularly to the main vain. Ten unwounded plants for
each line were also used as uninduced control. Four days
following PhRIP I induction, two leaves of each of the 10 plants
were infected with PVX as described before. The number of
lesions on infected leaves was determined 7 days after infection
and the significance of the data was assessed by Duncan
grouping analysis. The percentage of inhibition of lesion
formation in the wounded transgenic lines refers to the number
of lesions of the wounded untransformed plants.
3. Results
3.1. Translational inhibitory activity of the PhRIP I
The inhibitory effect of the PhRIP I purified from leaves of
the Phytolacca heterotepala (Fig. 1a and b) on translation was
estimated by a cell-free system (rabbit reticulocyte lysate). As
shown in Fig. 1c, the incorporation of 14C-leucine in neo-
synthesized proteins gradually decreased as the concentration
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of PhRIP I increased, indicating that the RIP inhibits protein
synthesis in vitro. The concentration of the protein causing 50%
inhibition (IC50) in the in vitro translation system was 0.065 nM
(1.96 ng/ml), calculated by linear-regression analysis. Protein
synthesis was completely inhibited by PhRIP I at concentration
of about 100 ng/ml.
3.2. In vitro antiviral activity of PhRIP I
A local lesion assay was performed to establish the
usefulness of the PhRIP I in suppressing PVX infection of
tobacco plants. Nicotiana tabacum cv. Samsun NN was used as
host plant because the N gene controls the hypersensitive
reaction, and plants respond to PVX infection by forming
necrotic lesions at the site of infection. Different concentrations
of RIP were tested and if the PhRIP I prevents PVX infection,
the formation of necrotic lesions is inhibited (Fig. 2). Table 1
shows the mean number of lesions on half leaves inoculated
with the PhRIP I and PVX and on opposite control half leaves
inoculated with PVX alone. The data indicated that the PhRIP I
has a significant antiviral activity at the different concentrations
employed.
3.3. The PhRIP I produced in tobacco by transient
expression maintains its antiviral activity
To demonstrate that tobacco plants can produce an antiviral
PhRIP I protein, we used an assay based on the infiltration of
leaves with Agrobacterium tumefaciens. This also allowed us to
verify the potential of this transient expression system for RIP
production, as plants have been proposed as alternative
biological system to yield proteins of possible pharmaceutical
interest [20]. To this aim, we cloned the PhRIP I cDNA under
the control of the 35S RNA CaMV constitutive promoter in a
derivative of the high-copy number vector pG0029 [23],
yielding the pG2935SRIP. As control we used the empty vector
(Fig. 3). Following agroinfiltration, total soluble proteins were
isolated after 4 days of incubation. The presence of the PhRIP I
Fig. 1. Purification and translational inhibitory activity of PhRIP I. (a) Coomassie blue staining of the purified PhRIP I resolved by SDS–PAGE. Lanes 1 and 2 were
loaded with molecular mass marker (Invitrogen) and 400 ng of PhRIP I, respectively; (b) Western blot analysis of 4 ng of purified PhRIP I using the PD-L4 antibody;
(c) dose-dependent inhibitory activity curve of the PhRIP I on rabbit reticulocyte lysate. Protein synthesis is expressed as percentage of the control mean value. The
error bars indicate the standard deviation for the average of two independent experiments each performed in triplicate.
Fig. 2. Inhibition by PhRIP I of local lesion formation by PVX on N. tabacum cv. Samsun NN leaves. The left half of the leaf was treated with PVX and PhRIP I
protein at the concentration indicated on the top whereas the right half was treated with PVX alone.
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in the protein extract was analysed by a Western blot assay
(Fig. 4). The analysis revealed other immunoreactive products,
present also in the protein extract from leaves infiltrated with
the agrobacterium carrying the empty vector. For that reason,
we used an analytical procedure to prepare and sequence the N-
terminus of the band of the expected molecular weight. Several
peaks absorbing at 280 nm (numbered from 1 to 6) were
obtained from the last analytical step (Fig. 5) but only peak 2
had polynucleotide–adenosine glycosidase activity. AWestern
blot assay indicated that this fraction included at least two
bands, of approximately 30 kDa (Fig. 6), that are detected by
the antiserum raised against PD-L4, a type 1 Ribosome-
Inactivating Protein isolated from Phytolacca dioica leaves
[30]. The bands, transferred to a PVDF membrane, were
subjected to Edman degradation. Band 1, with MW of about
30 kDa (Fig. 6), showed the N-terminal amino acid sequence
(VNTII YNVGS TTISK) identical to the corresponding
sequence of the mature native PhRIP I. On the contrary, for
the sequence of the band 2 (obtained with a lower yield) a
significant correspondence to any of the currently known
Ribosome-Inactivating Proteins was not found. The data
demonstrated that tobacco leaves infiltrated with recombinant
Agrobacteria produced a correctly processed PhRIP I. An
estimation of its quantity, carried out by quantifying the
intensity of the RIP specific immuno-signal in comparison with
known amount of the purified PhRIP I (Fig. 4), indicated the
presence of 1.2  0.1 mg per mg of total soluble proteins. Such
quantification was needed to perform a local lesion inhibition
assay against PVX, to test if the PhRIP I produced in tobacco
retains its antiviral activity. In this assay, we used an inoculum
Fig. 3. Schematic representation of the T-DNA region of the binary vectors employed, showing the position of the restriction sites used for cloning. Grey arrows
represent coding sequences. black areas cis-controlling elements. RB: T-DNA right border sequence; nos pro: nopaline synthase gene promoter; npt II: neomycin
phosphotransferase gene; nos ter: poly(A) addition sequence of the nos gene; LB: T-DNA left border sequence; 35S: CaMV 35S RNA gene promoter; 35S ter: poly(A)
addition sequence of the CaMV 35S RNA gene; PGIP Pro: bean polygalacturonase inhibitor I gene promoter; PhRIP I: Phytolacca heretotepala RIP I cDNA
sequence.
Fig. 4. Western blot analysis of the accumulation of the PhRIP I protein
transiently expressed in tobacco. Different amounts of a crude protein extract
(CPE) were subjected to SDS–PAGE along with different amounts of purified
PhRIP I. (1) CPE (60 mg) from leaves agroinfiltrated with the empty vector
pG0029M; (2) NN (60 mg); (3, 4 and 5) CPE (30, 45 and 60 mg) from leaves
agroinfiltrated with the pG2935SRIP; (6, 7 and 8) PhRIP I (1.9, 3.8 and 7.6 ng)
purified from Phytolacca heterotepala.
Fig. 5. Chromatographic elution profile from the gel-filtration on the HiLoad
16/60 SephadexTM 75 column of the final purification step of PhRIP I from
tobacco leaves. Only peak 2 (bar; MW ﬃ 30 kDa) showed polynucleotide-
adenosine glycosidase activity.
Table 1
Effect of PhRIP I on PVX infection to tobacco leaves
[PhRIP I]
(mg/ml)
Mean number of lesions per
half leaf
Inhibition
(%)
Probability
level
PVX PVX + PhRIP I
10.0 117.3 1.7 99 <0.001
1.0 73.1 2.9 96 <0.001
0.1 63.8 9.8 76 <0.001
Individual values for lesion numbers are the mean of 10 replicates. The
concentration of the PVX inoculum was 0.5 mg/ml.
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(0.5 mg/ml of PVX) with 0.18 mg/ml of PhRIP I in the CPE. At
this concentration, the purified protein from P. heterotepala
gave a 79% inhibition of the lesion formation (the mean number
of lesion was 92.0 for the PVX alone and 19.2 for the PVX with
the PhRIP I). As control for the CPE with the recombinant
PhRIP I, we used a PVX inoculumwith an equivalent amount of
total proteins in the CPE extracted from tobacco leaves
agroinfiltrated with the empty vector. The percentage of
inhibition of lesion formation was 93% (Table 2). In a parallel
experiment, we also calculated the inhibition of lesion
formation of the recombinant PhRIP I in the CPE compared
to the buffer, which was 99% (Table 2). Overall, the data
indicated that the PhRIP I enzyme maintains its antiviral
activity when expressed in tobacco.
3.4. Antiviral activity of the PhRIP I in transgenic tobacco
To test if PhRIP I can increase virus resistance in planta, the
possible protective effect of the protein was analysed in
infection experiments with PVX with transgenic tobacco lines
that express the PhRIP I under the control of the wound-
inducible PGIP promoter (Fig. 3) [29]. After PVX inoculation,
the number of necrotic lesions was determined on each infected
leaf in both induced and untreated plants of four transgenic
lines and of the Samsun NN untransformed control (Table 3).
As expected, differences between the transgenic lines and the
wild-type tobacco were not observed when the expression of
the PhRIP I was not induced in the transgenic lines. Similarly,
statistical differences in the number of lesions were not
detected between wounded and un-wounded untransformed
control plants, indicating that in our conditions the mechanical
damage of the plants did not significantly alter tobacco
resistance to PVX. As also shown in Table 3, the number of
lesions in the induced transgenic lines was significantly lower
than that in the wild-type. Additionally, some differences were
observed among the transgenic lines. Although we could not
observe a complete protection, the reduction of viral symptoms,
which ranged from 56% (for the PGIRIP 1 line) to 81% (for the
PGIPRIP 2), demonstrated that the controlled expression of the
PhRIP I in tobacco (Fig. 7) confers a protective effect against
PVX infection.
4. Discussion
Although the biochemical properties of the RIPs are well
characterised, their biological function in plants is not fully
understood [6]. Several studies have reported that some type 1
RIPs show antifungal and/or antiviral activities when con-
stitutively expressed in plants and this is probably one of the
strongest arguments to support the view that RIPs are involved
in plant defence against biotic stress [1]. The evidence available
suggests that RIP induction in plants could play a role in
increasing protection against pathogens, but it is not completely
clear weather or not RIPs are elements of the systemic acquired
resistance [15]. Furthermore, even if RIPs can be used to
increase virus resistance, a problem to be solved is the possible
Fig. 6. Western blot analysis of peak 2, using the polyclonal antiserum prepared
against PD-L4. Lane 1, PD-L4 (0.3 mg); lanes 2 and 3, peak 2 (0.8 and 1.6 mg,
respectively).
Table 2
Effect of the PhRIP I produced in tobacco on PVX infection to tobacco leaves
Mean number of lesions per half leaf Inhibition
(%)
Probability
level
PVX + control PVX + rPhRIP I in CPE
CPE 77.4 5.6 93 <0.001
Buffer 102.7 1.2 99 <0.001
Individual values for lesion numbers are the mean of 10 replicates. The
concentration of the PVX inoculum was 0.5 mg/ml. The concentration of the
recombinant PhRIP I produced in tobacco (rPhRIP I) was 0.18 mg/ml. Its
antiviral activity was compared to two controls, CPE (Crude Protein Extract
from agroinfiltrated tobacco leaves) and the buffer (50 mM Na–phosphate
buffer solution, pH 7.2).
Table 3
Duncan grouping analysis (P < 0.05) of the results of a bioassay of transgenic
PGIPRIP lines and the control tobacco (NN) infected with PVX
Line Inductiona Mean number of lesions Duncan group
NN ÿ 82.4 a
PGIPRIP 1 ÿ 98.1 a
PGIPRIP 2 ÿ 75.3 a
PGIPRIP 18 ÿ 88.7 a
PGIPRIP 37 ÿ 93.4 a
NN + 79.5 a
PGIPRIP 1 + 34.9 b
PGIPRIP 2 + 14.9 c
PGIPRIP 18 + 30.9 bc
PGIPRIP 37 + 18.2 bc
For each line 10 unwounded (ÿ) and 10 wounded (+) plants were infected with
PVX (0.5 mg/ml) and the number of lesions was counted after 7 days.
a The induction of the wound-inducible promoter controlling the PhRIP I
expression is indicated as absent (ÿ) or present (+).
Fig. 7. Western blot analysis of the transgenic PGIPRIP lines after wounding.
Protein extracts were prepared fromwounded leaf areas of transgenic plants and
from the untransformed Nicotiana tabacum ‘Samsun’ NN 4 days following the
treatment. Proteins (40 mg) were run in a 12% SDS–PAGE. (1) PGIPRIP 1; (2)
PGIPRIP 2; (3) NN; (4) PGIPRIP 18; (5) PGIPRIP 37.
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presence of phytotoxic effects due to constitutive expression of
these enzymes. For these reasons, one of our aims was to show
that the inducible expression of a RIP can increase virus
resistance in plants. Our study focused on the PhRIP I, a type I
RIP that was previously shown to increase fungal resistance in
tobacco [26]. To quantify the activity of the native protein, we
performed an inhibition assay of the translation process in a
cell-free system. The IC50 of the PhRIP I was significantly
higher than many RIPs, yet comparable to that of similar
enzymes purified from other Phytolacca species [31,32],
suggesting that our protein may exert its effects when also
present in small amount. Hence, the data make reasonable the
use of an inducible promoter for plant expression, as previous
studies showed that in transgenic tobacco expressing RIPs
under a strong constitutive promoter, the enhanced virus
resistance can occur at relatively low expression levels [8,33].
We first demonstrated that the PhRIP I has antiviral activity
in vitro against PVX and then we verified that tobacco plants
can produce a recombinant protein that retains this activity. As
the potential medical and agricultural applications of RIPs
continue to increase, we also wanted to test the agroinfiltration
technique as a means of a rapid plant-based production system.
The characterization of PhRIP I from tobacco leaves not only
provided the evidence that the protein maintains its antiviral
activity when ectopically expressed in tobacco but also
indicated that the protein is correctly synthesized and processed
by host cells, since the signal peptide was precisely cleaved
from the preprotein. N-terminal sequence of the native PhRIP I
indicated that the first 22 leading amino acids coded by its
cDNA sequence are removed [26]. Thus, P. heterotepala and
tobacco may possess similar mechanisms for the maturation of
this secretory sequence, even though database search does not
retrieve any large similarity between the PhRIP I signal peptide
and the tobacco sequences currently available. It has been
previously reported that, using a transient expression system
based on a plant RNA viral vector, the a-trichosanthin (a RIP
that also increases resistance against RNAviruses in plants [7])
is produced in tobacco in 2-weeks time [34]. Since tissue
containing the recombinant RIPs can be harvested 4 days after
agroinfiltration, our data proved the suitability of this method
for a very rapid production of RIP enzymes in plants. However,
if the overall quantity is a primary concern, the yield obtained
also implied that larger production of cytotoxic RIPs could be
achievable through the use of stable transgenic lines in which,
for instance, the coding sequence is under the control of a
promoter that could be chemically inducible.
To determine if transgenic lines expressing the PhRIP I are
more resistant to virus infection, plants of four different
independently transformed N. tabacum lines were screened for
resistance to PVX. Even if we did not assayed the N-
glycosidase activity in the transgenic plants, bioassays
demonstrated that upon the induction of the promoter
controlling the expression of the PhRIP I, the PGIPRIP lines
developed a statistically significant lower number of necrotic
lesions. In the transformed lines the number of lesions was
reduced up to 81% compared to untransformed plants.
Interestingly, a similar reduction in the number of lesions
was reported for the highly expressing PAP, PAPII and IRIP
tobacco transformants, in which the RIP coding sequence was
under the control of the 35S RNA constitutive promoter
[8,13,33]. It can be concluded that the controlled expression of
the PhRIP I exerts an in planta antiviral activity comparable to
that of other constitutively expressed RIPs. On the other hand,
the fact that without the induction of the transgene, we did not
detect differences in the resistance to PVX suggests that the
PGIP promoter is tightly regulated in our lines and it is not
activated by viral infection in tobacco, as expected [29].
Considering that the inducible expression of the PhRIP I can
also increase the resistance against different phytopatogenic
fungi [26], this work indicates that the constitutive expression
of RIPs is not necessary to exploit their multiple protective
effects in plants. Although it is not yet clear if stress-induction
is a universal phenomenon among plant RIPs [1], the inducible
resistance against different biotic stresses supports the
proposition that defence is an important component of RIP
biology. Furthermore, our data are also significant because
biotechnological strategies that can assure low level of RIPs to
increase pathogen resistance in plants should be favoured, as
different vegetables consumed as row food or feed display only
low RIP activities [35]. The improvement of inducible plant
expression systems for field applications is an interesting
perspective to assess in the future the biotechnological
usefulness of RIPs in an agricultural context.
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